Elizabeth Newbury
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elizabeth Newbury has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Christian Simon
Department of Internal Medicine, Division of Hematology, Oncology, Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics
3 shared publications Jamie L'HEureux
Department of 1Pediatrics, Carver College of Medicine, The University of Iowa , Iowa City, Iowa
2 shared publicationsJeffrey C. Murray
The University of Iowa
2 shared publicationsLaura Shinkunas
The University of Iowa
2 shared publicationsBridget Zimmerman
Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa
1 shared publication- George J. Weiner
Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA
1 shared publication
Latest Publications
- 29 May 2013
- Published by SAGE Publications in Biopreservation and Biobanking
- Vol. 11 (3) , 137-143
Public Perspectives on Biospecimen Procurement: What Biorepositories Should Consider
Purpose: Human biospecimens are central to biobanking efforts, yet how members of the public think about biobank procurement strategies is not well understood. This study aimed to explore public perspectives toward the procurement of residual clinical material versus “direct” procurement strategies such as the drawing of blood. Methods: Members of the public residing in and beyond the biobank catchment area of the University of Iowa Hospitals and Clinics were randomly selected to participate in focus groups and a telephone survey. Results: The majority of survey participants (75%, n =559) found both residual and direct procurement strategies equally workable. Small proportions preferred either residual (15%; n =117) or direct (5%; n =40) procurement. Focus group participants ( n =48) could identify benefits to both procurement strategies, but raised concerns about possible donor inconvenience/discomfort and reduced biospecimen accrual in the case of direct procurement. Residual procurement raised concerns about lower-quality samples being procured without full donor awareness. Conclusion: Biobanks should consider that members of the public in their research programs may be willing to make specimen donations regardless of whether a residual or direct procurement strategy is employed. Limiting patient discomfort and inconvenience may make direct procurement strategies more acceptable to some members of the public. Ensuring donor awareness through effective informed consent may allay public concerns about the indirectness of donating clinical biospecimens.
- 29 May 2013
- Published by SAGE Publications in Biopreservation and Biobanking
- Vol. 11 (3) , 137-143
Public Perspectives on Biospecimen Procurement: What Biorepositories Should Consider
Purpose: Human biospecimens are central to biobanking efforts, yet how members of the public think about biobank procurement strategies is not well understood. This study aimed to explore public perspectives toward the procurement of residual clinical material versus “direct” procurement strategies such as the drawing of blood. Methods: Members of the public residing in and beyond the biobank catchment area of the University of Iowa Hospitals and Clinics were randomly selected to participate in focus groups and a telephone survey. Results: The majority of survey participants (75%, n =559) found both residual and direct procurement strategies equally workable. Small proportions preferred either residual (15%; n =117) or direct (5%; n =40) procurement. Focus group participants ( n =48) could identify benefits to both procurement strategies, but raised concerns about possible donor inconvenience/discomfort and reduced biospecimen accrual in the case of direct procurement. Residual procurement raised concerns about lower-quality samples being procured without full donor awareness. Conclusion: Biobanks should consider that members of the public in their research programs may be willing to make specimen donations regardless of whether a residual or direct procurement strategy is employed. Limiting patient discomfort and inconvenience may make direct procurement strategies more acceptable to some members of the public. Ensuring donor awareness through effective informed consent may allay public concerns about the indirectness of donating clinical biospecimens.
- 1 September 2011
- Published by Elsevier in Genetics in Medicine
- Vol. 13 (9) , 821-831
Active choice but not too active: Public perspectives on biobank consent models
- 1 September 2011
- Published by Elsevier in Genetics in Medicine
- Vol. 13 (9) , 821-831
Active choice but not too active: Public perspectives on biobank consent models
- 1 September 2011
- Published by SAGE Publications in Journal of Empirical Research on Human Research Ethics
- Vol. 6 (3) , 19-30
Protecting Participants, Promoting Progress: Public Perspectives on Community Advisory Boards (CABs) in Biobanking
Few studies have explored public perspectives on community advisory board (CAB) involvement in biobank-based research. This study held focus groups (n = 7) with 48 individuals residing in the catchment of an emerging comprehensive tissue and DNA biobank in the state of Iowa. Participants recognized benefits of bringing CABs into biobank oversight, including additional levels of protection they could afford research participants. Yet, CAB goals of protecting participants were also seen as potentially antithetical to research and medical progress. Participants expressed uncertainty about the relationship of CABs to IRBs, communities, and industry. Findings suggest members of the public are in principle supportive of CAB involvement in biobanking, yet anticipate a range of problems and concerns. These perceptions will need to be proactively addressed.
- 1 September 2011
- Published by SAGE Publications in Journal of Empirical Research on Human Research Ethics
- Vol. 6 (3) , 19-30
Protecting Participants, Promoting Progress: Public Perspectives on Community Advisory Boards (CABs) in Biobanking
Few studies have explored public perspectives on community advisory board (CAB) involvement in biobank-based research. This study held focus groups (n = 7) with 48 individuals residing in the catchment of an emerging comprehensive tissue and DNA biobank in the state of Iowa. Participants recognized benefits of bringing CABs into biobank oversight, including additional levels of protection they could afford research participants. Yet, CAB goals of protecting participants were also seen as potentially antithetical to research and medical progress. Participants expressed uncertainty about the relationship of CABs to IRBs, communities, and industry. Findings suggest members of the public are in principle supportive of CAB involvement in biobanking, yet anticipate a range of problems and concerns. These perceptions will need to be proactively addressed.